Tamara Giebisch advises national and international clients on all aspects of intellectual property law with a focus on Life Sciences & Healthcare. 

She specialises in advising pharmaceutical, biotech and medtech companies on patent and medical device law. 

She also represents her clients in litigation, primarily in patent infringement proceedings. 

Tamara studied law at the Ludwig-Maximilians-University in Munich and the School of Business, Economics and Law in Gothenburg, Sweden. 

She completed her legal traineeship at the Higher Regional Court of Munich and spent one stage of her traineeship in Barcelona. Along with her legal traineeship, she worked for a leading international law firm. 

Tamara joined Osborne Clarke in May 2022. 

SwissHealth Ventures and Capricorn Partners

Osborne Clarke has provided legal advice to SwissHealth Ventures, the venture capital arm of Swiss health insurer CSS, and Belgian investor Capricorn Partners on a EUR 11 million seed financing round in Frankfurt-based healthtech start-up Oska Health. Read more.

Gilde Healthcare

Osborne Clarke has advised the healthcare‑focused investor Gilde Healthcare on the acquisition of a majority stake in the Physio CKI Group from Kapital 1852. Read more.

MAP Group

Osborne Clarke has advised MAP Group, a portfolio company of private equity firm Kester Capital, on the acquisition of SKC Beratungsgesellschaft mbH. Read more.

Contact Tamara
Add to contacts
Share

Insights

Showing 1 - 2 of 2